Milenko Jovan Tanasijevic
| Milenko Jovan Tanasijevic | |
|---|---|
| Born | Skopje, North Macedonia |
| 🏳️ Nationality | American–Macedonian |
| 🎓 Alma mater | Saints Cyril and Methodius University (MD) Boston University Questrom School of Management (MBA) Harvard Business School (Certificate) |
| 💼 Occupation | |
| Known for | Cardiac biomarkers, laboratory management, clinical decision support, diagnostics innovation |
Milenko Jovan Tanasijevic, MD, MBA, is an American clinical pathologist and academic. He is Editor-in-Chief of Clinics in Laboratory Medicine, Visiting Scholar and Mentor at the Wyss Institute at Harvard University, and a former Vice Chair of Clinical Pathology and Quality at Brigham and Women’s Hospital.[1][2]
Early life and education
Tanasijevic was born in Skopje, North Macedonia. He earned his MD from Saints Cyril and Methodius University in 1987, completed a residency in Clinical Pathology at Brigham and Women’s Hospital from 1990 to 1993, and joined the faculty of Harvard Medical School in 1993. He later earned an MBA from Boston University’s Questrom School of Management in 2004 and a Certificate in Entrepreneurship from Harvard Business School Online in 2023.[3]
Career
Academic and hospital roles
At Brigham and Women’s Hospital, Tanasijevic served as Medical Director of Clinical Chemistry (1993–2002), Director of Clinical Laboratories (2002–2020), and Vice Chair of Clinical Pathology and Quality (2002–2022).[4] He was also Director of Clinical Laboratories at Dana-Farber Cancer Institute from 1999 to 2016, and held the rank of Associate Professor of Pathology at Harvard Medical School.[5]
He has been quoted in trade press on laboratory operations and process redesign, including in *CAP Today* regarding changes in outpatient phlebotomy at Brigham and Dana-Farber.[6]
Research and innovation
Tanasijevic co-authored a multicenter study in the New England Journal of Medicine that evaluated cardiac-specific troponin I for risk stratification in acute coronary syndromes.[7]
His group also reported a slide-based, image-analysis approach to the complete blood count; the work was covered in trade press.[8][9]
He is listed as co-inventor on several U.S. patents related to diagnostic technologies.[10] Technology from his startup Cell Imaging Systems was later associated with Constitution Medical Investors, which Roche acquired in 2013 for US$220 million up front.[11][12][13]
References
- ↑ "Editorial board – Clinics in Laboratory Medicine". Elsevier. Retrieved 2025-09-05.
- ↑ "Milenko Jovan Tanasijevic, M.D., M.B.A." Wyss Institute. 27 February 2023. Retrieved 2025-09-05.
- ↑ "Milenko Jovan Tanasijevic, M.D., M.B.A." Harvard Catalyst. Retrieved 2025-09-05.
- ↑ "Dr. Milenko Tanasijevic, MD – Pathology". Doximity. Retrieved 2025-09-05.
- ↑ "Milenko Tanasijevic". Lab Quality Confab. 31 August 2018. Retrieved 2025-09-05.
- ↑ "Lab shoots for better phlebotomy service, satisfied patients". CAP Today. Retrieved 2025-09-05.
- ↑ Antman, E.M.; Tanasijevic, M.J.; Thompson, B.; Schactman, M.; McCabe, C.H.; Cannon, C.P.; Braunwald, E. (1996-10-31). "Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes". The New England Journal of Medicine. 335 (18): 1342–1349. doi:10.1056/NEJM199610313351802. PMID 8857017.
- ↑ Winkelman, J.W.; Tanasijevic, M.J.; Zahniser, D.J. (2017). "A Novel Automated Slide-Based Technology for Visualization, Counting, and Characterization of the Formed Elements of Blood: A Proof-of-Concept Study". Archives of Pathology & Laboratory Medicine. 141 (8): 1107–1114. doi:10.5858/arpa.2016-0633-OA. PMID 28421831.
- ↑ "Automated Slide-Based Approach Introduced for CBCs". LabMedica. 2017-09-14. Retrieved 2025-09-05.
- ↑ "Patents by Inventor Milenko Tanasijevic". Google Patents. Retrieved 2025-09-05.
- ↑ Winkelman, J.W.; Tanasijevic, M.J.; Zahniser, D.J. (2017). "A Novel Automated Slide-Based Technology for Visualization, Counting, and Characterization of the Formed Elements of Blood: A Proof-of-Concept Study". Archives of Pathology & Laboratory Medicine. 141 (8): 1107–1114. doi:10.5858/arpa.2016-0633-OA. PMID 28421831.
- ↑ "Roche Buys CMI, Creates Hematology Dx Hub In $220M+ Deal". Genetic Engineering & Biotechnology News. 2013-07-03. Retrieved 2025-09-05.
- ↑ "Roche Buys Constitution Medical for $220 Million Plus Payments". Bloomberg. 2013-07-02. Retrieved 2025-09-05.
External links
- Wyss Institute profile
- Harvard Catalyst profile
- LabQualityConfab bio
- Doximity profile
- Elsevier editorial board
This article "Milenko Jovan Tanasijevic" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Milenko Jovan Tanasijevic. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
